Ligand validation:3D0I

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3D0I designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3D0I_NAG_E_91	2%	46%	0.126	0.381	0.77	1.3	-	2	2	0	100%	1
6WAQ_NAG_D_602	78%	76%	0.095	0.937	0.4	0.53	-	-	0	0	100%	0.9333
2AJF_NAG_A_1322	47%	38%	0.121	0.859	0.56	1.83	-	1	0	0	100%	0.9333
7FC6_NAG_S_601	16%	32%	0.274	0.841	1.05	1.64	1	2	0	0	100%	0.9333
7JN5_NAG_F_601	14%	42%	0.351	0.904	0.98	1.28	-	3	0	0	100%	0.9333
8WCG_NAG_A_601	13%	64%	0.152	0.692	0.54	0.83	-	2	1	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.